Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAK1 | Q13153 | 2/20 | 0.52 |
| ▸ | PRKDC | P78527 | 14/20 | 0.48 |
| ▸ | CNR1 | P21554 | 2/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.42 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4021294 | 0.91 | PAK1 (0.61) | PAK1PRKDC | |
| SCHEMBL4582674 | 0.88 | PAK1 (0.65) | PAK1CNR1CNR2MAP3K5 | |
| SCHEMBL4018639 | 0.86 | PAK1 (0.42) | PAK1PRKDCCNR1CNR2KCNH2 | |
| SCHEMBL4025750 | 0.82 | PAK1 (0.66) | PAK1CNR1CNR2MAP3K5 | |
| SCHEMBL4024828 | 0.81 | PAK1 (0.51) | PAK1CNR1CNR2MAP3K5 | |
| SCHEMBL4017243 | 0.80 | PAK1 (0.49) | PAK1PRKDCMAP3K5 | |
| SCHEMBL4023766 | 0.79 | PAK1 (0.66) | PAK1CNR1CNR2MAP3K5 | |
| SCHEMBL4024568 | 0.79 | PAK1 (0.68) | PAK1CNR1CNR2MAP3K5 | |
| SCHEMBL4019364 | 0.79 | PAK1 (0.68) | PAK1CNR1CNR2MAP3K5 | |
| SCHEMBL4016900 | 0.79 | PAK1 (0.54) | PAK1PRKDCCNR1CNR2MAP3K5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2066654-A1 | N-(1-HETARYLPIPERIDIN-4-YL)(HET)ARYLAMIDES AS EP2 RECEPTOR MODULATORS | Bayer Schering Pharma AG (DE) | 2009-06-10 | — | — | EP | disclosed |
| WO-2008028691-A1 | N-(1-HETARYLPIPERIDIN-4-YL)(HET)ARYLAMIDES AS EP2 RECEPTOR MODULATORS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-03-13 | — | — | WO | disclosed |